Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Diseases With Unmet …GlobeNewswire (press release)NEW YORK, Dec. 05, 2017 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceut… Continue reading
Genetic Literacy ProjectGenetic engineering, synthetic biology poised to boost photosynthesis and carbon captureGenetic Literacy ProjectThe GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the lin… Continue reading
The Ledger Gazette |
CRISPR Therapeutics (CRSP) Oral Presentation of New Data on CTX001 at ASH
StreetInsider.com Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. CRISPR Therapeutics (NASDAQ: CRSP) today announced that Dr. Bill Lundberg, Chief Scientific Officer of CRISPR, is scheduled to present new … What’s Happening To These Stocks? – Vantiv, Inc. (VNTV), CRISPR Therapeutics AG (CRSP)Post Analyst Crispr Therapeutics (CRSP) Rating Lowered to Hold at BidaskClub …The Ledger Gazette The Tyler Dylan-Hyde Sells 21639 Shares of Crispr Therapeutics AG (CRSP) StockBangaloreWeekly HuronReport –Melville Review –Berry Recorder all 11 news articles » |
|
CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Medicine for β …
GlobeNewswire (press release) CTX001 is an investigational CRISPR gene-edited therapy for patients suffering from β-thalassemia and sickle cell disease in which a patient’s hematopoietic stem cells are engineered to produce high level of fetal hemoglobin (HbF; hemoglobin F) in red … What’s Happening To These Stocks? – Vantiv, Inc. (VNTV), CRISPR Therapeutics AG (CRSP)Post Analyst Crispr Therapeutics (CRSP) Rating Lowered to Hold at BidaskClub …The Ledger Gazette The Tyler Dylan-Hyde Sells 21639 Shares of Crispr Therapeutics AG (CRSP) StockBangaloreWeekly HuronReport –Street Observer (press release) –Week Herald all 10 news articles » |